[Tinidazole: a classical anaerobical drug with multiple potential uses nowadays].
Tinidazole is a 5-nitroimidazole active in vitro against a wide variety of anaerobic bacteria and protozoa. Tinidazole is an effective treatment against anaerobic microorganisms based on its pharmacokinetic characteristics (C(max) 51 microg/ml, t(1/2) 12.5 h) and its excellent in vitro activity. Its long half-life allows once a day regimens. Tinidazole is as effective as metronidazole in the treatment of infections caused by T. vaginalis, giardiasis and amebiasis and bacterial vaginosis, malaria, odontogenic infections, anaerobic bacterial infections (pelvic inflammatory disease, diabetic foot), surgical prophylaxis (abdominal and hysterectomy) and Helicobacter pylori eradication. Tinidazole was recently approved by the Food and Drug Administration (FDA) for the treatment of infections caused by Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia.
Granizo
J J
JJ
Grana Datos, SL, 28223 Pozuelo de Alarcón, Madrid. jjgranizo@granadatos.com
Pía Rodicio
M
M
Manso
F J
FJ
Giménez
Ma José
MJ
D000693:Anaerobiosis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004749:Entamoebiasis / Q000188:drug therapy; D056890:Eukaryota / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D005873:Giardiasis / Q000188:drug therapy; D016481:Helicobacter Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D010518:Periodontitis / Q000188:drug therapy; D011183:Postoperative Complications / Q000517:prevention & control; D014011:Tinidazole / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D014245:Trichomonas Infections / Q000188:drug therapy; D016585:Vaginosis, Bacterial / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D014011:Tinidazole